Authors: AVRAMIS VI NANDY P KWOCK R SOLORZANO MM MUKHERJEE SK DANENBERG P COHEN LJ

Citation: Vi. Avramis et al., INCREASED P21 WAF-1 AND P53 PROTEIN-LEVELS FOLLOWING SEQUENTIAL 3-DRUG-COMBINATION REGIMEN OF FLUDARABINE, CYTARABINE AND DOCETAXEL INDUCESAPOPTOSIS IN HUMAN LEUKEMIA-CELLS/, Anticancer research, 18(4A), 1998, pp. 2327-2338

Authors: WU SJ LIU XP SOLORZANO MM KWOCK R AVRAMIS VI

Citation: Sj. Wu et al., DEVELOPMENT OF ZIDOVUDINE (AZT) RESISTANCE IN JURKAT T-CELLS IS ASSOCIATED WITH DECREASED EXPRESSION OF THE THYMIDINE KINASE (TK) GENE AND HYPERMETHYLATION OF THE 5'-END OF HUMAN TK GENE, Journal of acquired immune deficiency syndromes and human retrovirology, 8(1), 1995, pp. 1-9

Authors: AVRAMIS VI KWOCK R SOLORZANO MM GOMPERTS E

Citation: Vi. Avramis et al., EVIDENCE OF IN-VITRO DEVELOPMENT OF DRUG-RESISTANCE TO AZIDOTHYMIDINEIN T-LYMPHOCYTIC LEUKEMIA-CELL LINES (JURKAT E6-1 AZT-100) AND IN PEDIATRIC-PATIENTS WITH HIV-1 INFECTION/, Journal of acquired immune deficiency syndromes, 6(12), 1993, pp. 1287-1296

Authors: AVRAMIS VI CHAN KK SOLORZANO MM CHEN ZL

Citation: Vi. Avramis et al., PRECLINICAL PHARMACOLOGY OF THE ANTITUMOR AGENT O-6-METHYLGUANINE IN CDF1 MICE, Cancer chemotherapy and pharmacology, 33(3), 1993, pp. 197-202